These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15961297)

  • 1. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.
    Sugawara M; Kadomura S; He X; Takekuma Y; Kohri N; Miyazaki K
    Eur J Pharm Sci; 2005 Sep; 26(1):1-8. PubMed ID: 15961297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption.
    He X; Kadomura S; Takekuma Y; Sugawara M; Miyazaki K
    J Pharm Sci; 2004 Jan; 93(1):71-7. PubMed ID: 14648637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier.
    Mizoguchi M; Kataoka M; Yokoyama K; Aihara R; Wada K; Yamashita S
    J Pharm Sci; 2018 Sep; 107(9):2404-2410. PubMed ID: 29802932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.
    Matsui K; Tsume Y; Amidon GE; Amidon GL
    Mol Pharm; 2015 Jul; 12(7):2418-28. PubMed ID: 25985298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract.
    Kobayashi M; Sada N; Sugawara M; Iseki K; Miyazaki K
    Int J Pharm; 2001 Jun; 221(1-2):87-94. PubMed ID: 11397570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
    Heigoldt U; Sommer F; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility.
    Gu CH; Rao D; Gandhi RB; Hilden J; Raghavan K
    J Pharm Sci; 2005 Jan; 94(1):199-208. PubMed ID: 15761943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
    Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
    Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
    Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
    Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Itoh K; Hirayama T; Takahashi A; Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2007 Apr; 335(1-2):90-96. PubMed ID: 17141988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Absorption Site-Guided Development and Evaluation of Oral Disintegrating Controlled Release Tablets of Mirabegron.
    Ghanem MI; Ashmawy SM; El Maghraby GM
    AAPS PharmSciTech; 2024 Jul; 25(6):167. PubMed ID: 39043962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
    Walsh PL; Bothe JR; Bhardwaj S; Hu M; Nofsinger R; Xia B; Persak S; Pennington J; Bak A
    Drug Dev Ind Pharm; 2016; 42(5):836-44. PubMed ID: 26339722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen.
    Itoh K; Kubo W; Fujiwara M; Watanabe H; Miyazaki S; Attwood D
    Biol Pharm Bull; 2006 Feb; 29(2):343-7. PubMed ID: 16462043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.